FDA
approval
· 2025-05-13
FDA Approved: PIOGLITAZONE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
Summary
The FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market Pioglitazone and Metformin Hydrochloride as a fixed-dose combination …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PIOGLITAZONE AND METFORMIN HYDROCHLORIDE (PIOGLITAZONE AND METFORMIN HYDROCHLORIDE)